Interest Income Expense - Mabwell Shanghai Bioscience Co Ltd (SSE:688062) - Alpha Spread
M

Mabwell Shanghai Bioscience Co Ltd
SSE:688062

Watchlist Manager
Mabwell Shanghai Bioscience Co Ltd
SSE:688062
Watchlist
Price: 21.24 CNY -0.28% Market Closed
Market Cap: 8.5B CNY
Have any thoughts about
Mabwell Shanghai Bioscience Co Ltd?
Write Note

Mabwell Shanghai Bioscience Co Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Mabwell Shanghai Bioscience Co Ltd
Interest Income Expense Peer Comparison

Comparables:
6160
1801
9926
603392
300122

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
M
Mabwell Shanghai Bioscience Co Ltd
SSE:688062
Interest Income Expense
ÂĄ28.8m
CAGR 3-Years
24%
CAGR 5-Years
87%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Interest Income Expense
-ÂĄ59.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Interest Income Expense
ÂĄ445.8m
CAGR 3-Years
N/A
CAGR 5-Years
84%
CAGR 10-Years
N/A
Akeso Inc
HKEX:9926
Interest Income Expense
-ÂĄ106.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Interest Income Expense
ÂĄ217.7m
CAGR 3-Years
N/A
CAGR 5-Years
134%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Interest Income Expense
-ÂĄ45.8m
CAGR 3-Years
27%
CAGR 5-Years
-2%
CAGR 10-Years
N/A

See Also

What is Mabwell Shanghai Bioscience Co Ltd's Interest Income Expense?
Interest Income Expense
28.8m CNY

Based on the financial report for Dec 31, 2023, Mabwell Shanghai Bioscience Co Ltd's Interest Income Expense amounts to 28.8m CNY.

What is Mabwell Shanghai Bioscience Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
87%

Over the last year, the Interest Income Expense growth was -21%. The average annual Interest Income Expense growth rates for Mabwell Shanghai Bioscience Co Ltd have been 24% over the past three years , 87% over the past five years .

Back to Top